Skip to main content

Advertisement

SpringerLink
Log in

Post-prandial glucose and diabetic complications: systematic review of observational studies

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Post-prandial hyperglycemia is considered a relevant therapeutic target in type 2 diabetic patients, and it could represent per se an independent risk factor for diabetic complications. Aim of the present systematic review is to collect and summarize evidence from observational studies on the relationship between post-prandial glucose (PPG) and cardiovascular or microvascular disease in patients with diabetes. An extensive search of Medline (any date up to December 31, 2010) was performed for all longitudinal epidemiological studies with a cohort design. The following endpoints were taken into consideration: death from any cause; cardiovascular death and micro- and macrovascular complications. The number of epidemiological studies assessing the relationship between PPG and microvascular or cardiovascular disease in subjects with diabetes is surprisingly scarce. In fact, of the 391 retrieved studies, only 8 fulfilled the inclusion criteria. Most of those investigations enrolled small samples, which in many instances were not representative of the general population. Furthermore, the assessment of PPG varied widely across studies. These considerations prevent any formal meta-analysis. Despite this, the few available studies show that higher PPG is associated with increased all-cause and cardiovascular death, incidence of major cardiovascular events (including myocardial infarction and stroke), and progression of diabetic retinopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Huxley R, Barzi F, Woodward M (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332:73–78

    Google Scholar 

  2. Wit MA, de Mulder M, Jansen EK, Umans VA (2010) Diabetes mellitus and its impact on long-term outcomes after coronary artery bypass graft surgery. Acta Diabetol 47:340–345

    Google Scholar 

  3. Ertek S, Cicero AF, Cesur M, Akcil M, Altuner Kayhan T, Avcioglu U, Korkmaz ME (2011) The severity of coronary atherosclerosis in diabetic and non-diabetic metabolic syndrome patients diagnosed according to different criteria and undergoing elective angiography. Acta Diabetol 48:21–27

    Article  PubMed  CAS  Google Scholar 

  4. Tarquini R, Lazzeri C, Pala L, Rotella CM, Gensini GF (2011) The diabetic cardiomyopathy. Acta Diabetol 48:173–181

    Google Scholar 

  5. Poanta L, Porojan M, Dumitrascu DL (2011) Heart rate variability and diastolic dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol 48:191–196

    Google Scholar 

  6. Avogaro A, Giorda C, Maggini M, Mannucci E, Raschetti R, Lombardo F, Spila-Alegiani S, Turco S, Velussi M, Ferrannini E; Diabetes and Informatics Study Group, Association of Clinical Diabetologists, Istituto Superiore di Sanità (2007) Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care 30:1241–1247

    Google Scholar 

  7. Guo L, Cheng Y, Wang X, Pan Q, Li H, Zhang L, Wang Y (2010) Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol 47:323–329

    Google Scholar 

  8. Standards of medical care in diabetes–2011 (2011) Diabetes Care 34(Suppl 1):S11–S61

    Google Scholar 

  9. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986

    Google Scholar 

  10. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853

    Google Scholar 

  11. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572

    Google Scholar 

  12. Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM (2006) The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 55:3556–3565

    Article  PubMed  CAS  Google Scholar 

  13. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589

    Google Scholar 

  14. Gerstein HC, Miller ME, Byington RP, Goff DC, Jr., Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559

    Google Scholar 

  15. Mannucci E, Monami M, Lamanna C, Gori F, Marchionni N (2009) Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis 19:604–612

    Google Scholar 

  16. Monnier L, Lapinski H, Colette C (2003) Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26:881–885

    Article  PubMed  Google Scholar 

  17. Monami M, Lamanna C, Lambertucci L, Longo R, Cocca C, Addante F, Lotti E, Masotti G, Marchionni N, Mannucci E (2006) Fasting and post-prandial glycemia and their correlation with glycated hemoglobin in Type 2 diabetes. J Endocrinol Invest 29:619–624

    Google Scholar 

  18. DECODE Study Group, the European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405

    Google Scholar 

  19. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K (2006) Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur J Cardiovasc Prev Rehabil 13:555–561

    Google Scholar 

  20. Sorkin JD, Muller DC, Fleg JL, Andres R (2005) The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28:2626–2632

    Article  PubMed  Google Scholar 

  21. Levitan EB, Song Y, Ford ES, Liu S (2004) Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164:2147–2155

    Google Scholar 

  22. Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, Anfossi G, Costa G, Trovati M (2006) Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 91:813–819

    Google Scholar 

  23. Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–240

    Google Scholar 

  24. Ceriello A, Falleti E, Motz E, Taboga C, Tonutti L, Ezsol Z, Gonano F, Bartoli E (1998) Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res 30:146–149

    Google Scholar 

  25. Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Esposito K, Giugliano D (2004) Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53:701–710

    Article  PubMed  CAS  Google Scholar 

  26. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34:146–154

    Google Scholar 

  27. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681–1687

    Article  PubMed  CAS  Google Scholar 

  28. Hasegawa G, Yamamoto Y, Zhi JG, Tanino Y, Yamasaki M, Yano M, Nakajima T, Fukui M, Yoshikawa T, Nakamura N (2005) Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia. Acta Diabetol 42:179–181

    Article  PubMed  CAS  Google Scholar 

  29. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA (1998) Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97:1695–1701

    Article  PubMed  CAS  Google Scholar 

  30. von Harsdorf R, Li PF, Dietz R (1999) Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99:2934–2941

    Article  Google Scholar 

  31. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820

    Article  PubMed  CAS  Google Scholar 

  32. Gerich JE (2003) Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med 163:1306–1316

    Google Scholar 

  33. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A (2001) Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 281:E924–E930

    Google Scholar 

  34. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A (2003) Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52:2795–2804

    Article  PubMed  CAS  Google Scholar 

  35. Piconi L, Quagliaro L, Da Ros R, Assaloni R, Giugliano D, Esposito K, Szabo C, Ceriello A (2004) Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost 2:1453–1459

    Google Scholar 

  36. Kilpatrick ES, Rigby AS, Atkin SL (2008) Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes. Diabetologia 51:365–371

    Article  PubMed  CAS  Google Scholar 

  37. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J (1996) Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577–1583

    Article  PubMed  CAS  Google Scholar 

  38. Linnemann B, Voigt W, Nobel W, Janka HU (2006) C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome. Exp Clin Endocrinol Diabetes 114:127–134

    Article  PubMed  CAS  Google Scholar 

  39. Shiraiwa T, Kaneto H, Miyatsuka T, Kato K, Yamamoto K, Kawashima A, Kanda T, Suzuki M, Imano E, Matsuhisa M, Hori M, Yamasaki Y (2005) Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients. Diabetes Care 28:2806–2807

    Article  PubMed  Google Scholar 

  40. Liu QZ, Pettitt DJ, Hanson RL, Charles MA, Klein R, Bennett PH, Knowler WC (1993) Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses. Diabetologia 36:428–432

    Article  PubMed  CAS  Google Scholar 

  41. Kuusisto J, Mykkanen L, Pyorala K, Laakso M (1994) Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 25:1157–1164

    Article  PubMed  CAS  Google Scholar 

  42. Sievers ML, Bennett PH, Nelson RG (1999) Effect of glycemia on mortality in Pima Indians with type 2 diabetes. Diabetes 48:896–902

    Article  PubMed  CAS  Google Scholar 

  43. Ge QM, Dong Y, Zhang HM, Su Q (2010) Effects of intermittent high glucose on oxidative stress in endothelial cells. Acta Diabetol 47:97–103

    Article  PubMed  CAS  Google Scholar 

  44. Beisswenger PJ, Howell SK, O’Dell RM, Wood ME, Touchette AD, Szwergold BS (2001) Alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care 24:726–732

    Article  PubMed  CAS  Google Scholar 

  45. Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N (2006) Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study. J Clin Endocrinol Metab 91:837–842

    Google Scholar 

  46. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M (2004) Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25:10–16

    Google Scholar 

  47. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290:486–494

    Article  PubMed  CAS  Google Scholar 

  48. Esposito K, Giugliano D, Nappo F, Marfella R (2004) Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 110:214–219

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Agency, Department of Cardiovascular Medicine, Careggi Teaching Hospital, Azienda Ospedaliero-Universitaria Careggi, Via delle Oblate n. 4, 50141, Florence, Italy

    Edoardo Mannucci & Caterina Lamanna

  2. Section of Geriatric Cardiology and Medicine, Department of Cardiovascular Medicine, Careggi Teaching Hospital, Florence, Italy

    Matteo Monami

  3. HTA Unit Global Health Economics and Outcomes Research, Novo Nordisk, Sborg, Denmark

    Johan Erpur Adalsteinsson

Authors
  1. Edoardo Mannucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matteo Monami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Caterina Lamanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Johan Erpur Adalsteinsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edoardo Mannucci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mannucci, E., Monami, M., Lamanna, C. et al. Post-prandial glucose and diabetic complications: systematic review of observational studies. Acta Diabetol 49, 307–314 (2012). https://doi.org/10.1007/s00592-011-0355-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-011-0355-0

Keywords

Search

Navigation